These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31087724)

  • 1. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
    Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
    J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma grading using a machine-learning framework based on optimized features obtained from T
    Sengupta A; Ramaniharan AK; Gupta RK; Agarwal S; Singh A
    J Magn Reson Imaging; 2019 Oct; 50(4):1295-1306. PubMed ID: 30895704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
    Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
    Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
    Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
    Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
    J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
    Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
    BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Glioma Grading With Inflow-Based Vascular-Space-Occupancy MRI: A Preliminary Study at 3T.
    Li X; Liao S; Hua J; Guo L; Wang D; Xiao X; Zhou J; Liu X; Tan Y; Lu L; Xu Y; Wu Y
    J Magn Reson Imaging; 2019 Dec; 50(6):1817-1823. PubMed ID: 30932289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
    Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD
    Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of preoperative magnetic resonance imaging features and diagnostic effectiveness of grades II and III intracranial solitary fibroma.
    Ran Y; Wang X; Zhang Y; Chen R; Liu C; Ran Y; Wang W; Ma X; Wang M; Cheng J
    Eur J Med Res; 2024 Jul; 29(1):377. PubMed ID: 39030639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of susceptibility- and diffusion-weighted magnetic resonance imaging for grading gliomas.
    Xu J; Xu H; Zhang W; Zheng J
    Exp Ther Med; 2018 Jun; 15(6):5113-5118. PubMed ID: 29805537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.
    Raja R; Sinha N; Saini J; Mahadevan A; Rao KN; Swaminathan A
    Neuroradiology; 2016 Dec; 58(12):1217-1231. PubMed ID: 27796448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
    Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
    J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
    Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D
    Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.
    Kong LW; Chen J; Zhao H; Yao K; Fang SY; Wang Z; Wang YY; Li SW
    Sci Rep; 2019 Nov; 9(1):17080. PubMed ID: 31745161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.